Filter by: patients
Home > Community Treatment Reports and Side Effects > Combivir/Nevirapine Treatment Report
What is Combivir/Nevirapine?

This is a combination of the antiretroviral drug Combivir (a combination of lamivudine and zidovudine (AZT), and Nevirapine (brand name Viramune). This combination may simplify your therapy and reduce the rate of developing resistance to the separate drugs. Read more...Click to read more below

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
HIV (Human Immunodeficiency Virus) 7 1 Efficacy_slight
Swollen glands 1 0
Other 1 0

See all 7 patients currently taking Combivir/Nevirapine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 0

Commonly reported side effects, conditions, and hospitalizations associated with Combivir/Nevirapine

Peripheral neuritis 1
Numbness in feet 1

Reported Dosages

  daily 2 daily 2 tbs. daily 20 mg daily 40 mg daily 150 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Combivir/Nevirapine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 67%
Expense 1   Expense: 33%
Personal research 1   Personal research: 33%
Side effects too severe 1   Side effects too severe: 33%
Other 1   Other: 33%

See all 3 patients who’ve stopped taking Combivir/Nevirapine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Combivir/Nevirapine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Combivir/Nevirapine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Combivir/Nevirapine

Always
 1 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Combivir/Nevirapine

Very
 0 0%
Somewhat
 0 0%
A little
 1 100%
Not at all
 0 0%

Cost

Paid out of pocket

Cost of Combivir/Nevirapine

$200+
 0 0%
$100-199
 0 0%
$50-99
 0 0%
$25-49
 0 0%
< $25
 1 100%

Report created on February 10, 2012.